Hearing loss affects millions of people worldwide and can be caused by genetic defects in key proteins essential for auditory function. Recent research by Pedro De-la-Torre and colleagues (doi: https://doi.org/10.1101/2024.06.16.599132) has provided significant...
An 11-year-old boy who received Eli Lilly’s experimental gene therapy for hearing loss last October showed signs of restored hearing 30 days after treatment, the pharma giant announced on Tuesday. The therapy, dubbed AK-OTOF, is designed to deliver a functional copy...
Shanghai Refreshgene Technology Co., Ltd., in collaboration with the research groups from the Eye, Ear, Nose, and Throat Hospital affiliated with Fudan University, has made significant progress in gene therapy for hearing loss. Their innovation, the RRG-OTOF Dual...
Graphical abstract. Credit: Molecular Therapy (2023). DOI: 10.1016/j.ymthe.2023.05.005 By 2050, one in 10 individuals are expected to live with some form of hearing loss. Of the hundreds of millions of cases of hearing loss affecting individuals worldwide, genetic...
